Condensed Consolidated Statements of Cash Flows $ in Thousands	3 Months Ended
	Mar. 31, 2023 USD ($)	Mar. 31, 2022 USD ($)
Cash flows from operating activities:
Net loss	$ (23,447)	$ (4,342)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	296	248
Loss on disposal of property and equipment	0	6
Share-based compensation expense	207	116
Change in fair value of SAFE Agreements	2,353	(285)
Change in fair value of earn-out liabilities	3,726	0
Other	582	0
Changes in operating assets and liabilities:
Trade accounts receivable, net	(1,006)	(5,178)
Contract assets	(4,727)	(3,298)
Prepaid expenses	(2,785)	(397)
Other assets, net	178	78
Accounts payable	6,994	(133)
Accounts payable – affiliated companies	170	345
Contract liabilities – current and long-term	(8,140)	(9,675)
Other liabilities	6,933	(1,529)
Net cash used in operating activities	(18,666)	(24,044)
Cash flows from investing activities:
Purchase of property and equipment	(8,565)	(377)
Net cash used in investing activities	(8,565)	(377)
Cash flows from financing activities:
Proceeds from Business Combination	8,055	0
Proceeds from Series A Preferred Stock	26,000	0
Transaction costs	(782)	0
Repayment of loans	0	(64)
Proceeds from issuance of units	22	0
Forward purchase agreement termination	12,730	0
Warrants exercised	2,243	0
SAFE Agreements	0	4,250
Net cash provided by financing activities	48,268	4,186
Net increase (decrease) in cash, cash equivalents and restricted cash	21,037	(20,235)
Cash, cash equivalents and restricted cash at beginning of the period	25,826	29,351
Cash, cash equivalents and restricted cash at end of the period	46,863	9,116
Less: restricted cash	62	62
Cash and cash equivalents	46,801	9,054
Supplemental disclosure of cash flow information
Cash paid for interest, net	464	158
Cash paid for taxes	9	8
Noncash financing activities:
Transaction costs	(23,663)	0
SAFE Agreements	20,667	0
Cumulative preferred dividends	$ (328)	$ 0